Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alginate versus antacid for reflux symptom prevention during PPI discontinuation before endoscopy in scleroderma
TCTR20240916010Phase 3Recruiting
- Sponsor
- Witsarut Manasirisuk
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gaviscon advance in gastroesophageal reflux disease (GERD), sponsored by Witsarut Manasirisuk. Started Jun 2024; status: recruiting.
02
Drugs
gaviscon advance
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20240916010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240916010.